Candel Therapeutics (CADL) Earnings Date, Estimates & Call Transcripts → Proof that the Musk/Bezos rivalry is about to hit a new level (From InvestorPlace) (Ad) Free CADL Stock Alerts $9.97 -0.86 (-7.94%) (As of 05/9/2024 ET) Add Compare Share Share EarningsStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial MediaStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial Media Earnings SummaryLatest Earnings DateMar. 28EstimatedActual EPS (Mar. 28) -$0.38 Missed By -$0.22 Consensus EPS (Mar. 28) -$0.16 Get Candel Therapeutics Earnings AlertsEnter your email address below to receive the latest news and earnings results for CADL and its competitors with MarketBeat's FREE daily newsletter. Skip Charts & View Estimated and Actual Earnings DataEarnings Per ShareRevenueCADL Earnings Estimates and Actuals by QuarterEarnings Estimates and Acutals by Quarter Chart DescriptionThe chart below shows up to four years of a company's earnings history. The dark blue line represents the company's actual earnings per share. The light blue area represents the range of Wall Street analysts' earnings estimates for each quarter.CADL Estimated and Actual Revenue by Quarter Estimated Revenue and Actual Revenue by Quarter Chart DescriptionThe chart below shows up to four years of a company's revenue history. The dark blue line represents the company's actual revenue. The light blue line represents the company's estimated revenue based on the consensus of Wall Street analysts for each quarter. Ad Banyan Hill PublishingThe Best AI Stock to Own in the World Today is Trading for Just $25“Titan of Tech” Bets Big on Tiny AI Company He’s made as much as 3,250,000% in just three years on companies like Facebook, Airbnb, and PayPal… But our research shows his latest investment could be his most successful venture yet.See how you can invest alongside him Candel Therapeutics Analyst EPS EstimatesCurrent Year EPS Consensus Estimate:($0.91) EPSCADL Earnings Date and InformationCandel Therapeutics last issued its quarterly earnings data on March 28th, 2024. The reported ($0.38) earnings per share (EPS) for the quarter, missing analysts' consensus estimates of ($0.16) by $0.22. Candel Therapeutics has generated ($1.30) earnings per share over the last year (($1.30) diluted earnings per share). Read More Candel Therapeutics Earnings History by Quarter Custom Range 3 Months 6 Months Year-to-Date 1 Year 2 Years 3 Years 5 Years Time Frame * Start Date * End Date Export to Excel DateQuarterConsensus EstimateReported EPSBeat/MissGAAP EPSRevenue EstimateActual RevenueCall Transcript3/28/2024Q4 2023($0.16)($0.38)($0.22)($0.38)--11/9/2023Q3 2023($0.19)($0.29)($0.10)($0.29)--8/10/2023Q2 2023($0.23)($0.33)($0.10)($0.33)--5/11/2023Q1 2023-($0.30)($0.30)($0.30)--3/30/2023Q4 2022($0.16)($0.18)($0.02)($0.18)-$0.03 million11/10/2022Q3 2022($0.53)($0.30)+$0.23($0.30)-$0.03 million Get the Latest News and Ratings for CADL and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Candel Therapeutics and its competitors with MarketBeat's FREE daily newsletter. 8/5/2022Q2 2022($0.54)($0.14)+$0.40($0.14)-$0.03 million5/12/2022Q1 2022($0.49)($0.03)+$0.46($0.03)--3/29/2022Q4 2021-$0.05+$0.05$0.05-$0.03 million11/12/2021Q3 2021($0.27)($0.34)($0.07)$0.01-$0.03 million9/8/2021Q2 2021($0.36)($0.31)+$0.05$0.84-$0.03 million Candel Therapeutics Earnings - Frequently Asked Questions When did Candel Therapeutics announce their last quarterly earnings? Candel Therapeutics (NASDAQ:CADL) last announced its quarterly earning data on Thursday, March 28, 2024. Learn more on CADL's earnings history. Did Candel Therapeutics beat their earnings estimates last quarter? In the previous quarter, Candel Therapeutics (NASDAQ:CADL) missed the analysts' consensus estimate of ($0.16) by $0.22 with a reported earnings per share (EPS) of ($0.38). Learn more on analysts' earnings estimate vs. CADL's actual earnings. How much revenue does Candel Therapeutics generate each year? Candel Therapeutics (NASDAQ:CADL) has a recorded annual revenue of $120,000.00. How much profit does Candel Therapeutics generate each year? Candel Therapeutics (NASDAQ:CADL) has a recorded net income of -$37.94 million. CADL has generated -$1.30 earnings per share over the last four quarters. More Earnings Resources from MarketBeat Related Companies: STRO Earnings Date ADVM Earnings Date INMB Earnings Date CMPX Earnings Date CRDF Earnings Date ABOS Earnings Date CHRS Earnings Date IPSC Earnings Date XFOR Earnings Date ZURA Earnings Date Earnings Tools: Today's Earnings Tomorrow's Earnings Next Week's Earnings Upcoming Earnings Calls Earnings Newsletter Earnings Call Transcripts Earnings Beats & Misses Corporate Guidance Earnings Screener Earnings By Country: U.S. Earnings Reports Canadian Earnings Reports U.K. Earnings Reports Australia Earnings Reports Latest Articles: Traders Sell but Investors Still Win After Palantir's EarningsTech Earnings Insights: Where Opportunity Meets UncertaintyApple’s Earnings Show Investors Its Strength and Its WeaknessCarvana’s Q1 Earnings: A Profitability U-TurnPayPal’s Strong Earnings Growth and Strategic Evolution GE Aerospace is Ready for Liftoff After Strong EarningsTaiwan Semiconductor Earnings: AI Dominance and Future Outlook This page (NASDAQ:CADL) was last updated on 5/10/2024 by MarketBeat.com Staff From Our PartnersThe Crypto 9-5 Escape PlanCrypto 101 MediaHe Is Giving Away BitcoinCrypto Swap ProfitsForget AI, Imperium Is Expected to Grow 320,00% in 3 YearsBanyan Hill PublishingCharles Payne Demystifies OptionsUnstoppable ProsperityShocking: One AI startup's revenue could surge 4,735%Manward Press[URGENT] DO NOT Touch These AI Stocks!Weiss RatingsMissed NVDA? Buy this AI stock NOWChaikin AnalyticsGold ManiaStansberry Research Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Candel Therapeutics, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
